Dicky John Davis G

Dr. Dicky John Davis G

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2011 in Bioinformation
Verified
Journal Article
Open access
DGDicky John Davis G
Dicky John Davis G
AVA Hannah Rachel Vasanthi
A Hannah Rachel Vasanthi
The cataloguing of marine chemicals is a fundamental aspect for bioprospecting. This has applications in the development of drugs from marine sources. A publicly accessible database that provides comprehensive information about these compounds is therefore helpful. The Seaweed Metabolite Database (SWMD) is designed to provide information about the known compounds and their biological activity described in the literature. Geographical origin of the seaweed, extraction method and the chemical descriptors of each the compounds are recorded to enable effective chemo-informatics analysis. Crosslinks to other databases are also introduced to facilitate the access of information about 3D Structure by X-ray and NMR activity, drug properties and related literature for each compound. This database currently contains entries for 517 compounds encompassing 25 descriptive fields mostly from the Red algae of the genus Laurencia (Ceramiales, Rhodomelaceae). The customized search engine of this database will enable wildcard querying, which includes Accession Number, Compound type, Seaweed Binomial name, IUPAC name, SMILES notation or InChI. The database is available for free at http://www.swmd.co.in.

1 March 2011 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
VAV. Arul
V. Arul
JMJ. G. Masilamoni
J. G. Masilamoni
EJE. P. Jesudason
E. P. Jesudason
PJP. J. Jaji
P. J. Jaji
MIMohammed Inayathullah
Mohammed Inayathullah
Jayakumar RajadasJayakumar Rajadas
Jayakumar Rajadas
Impaired wound healing in diabetes is a well-documented phenomenon. Emerging data favor the involvement of free radicals in the pathogenesis of diabetic wound healing. We investigated the beneficial role of the sustained release of reactive oxygen species (ROS) in diabetic dermal wound healing. In order to achieve the sustained delivery of ROS in the wound bed, we have incorporated glucose oxidase in the collagen matrix (GOIC), which is applied to the healing diabetic wound. Our in vitro proteolysis studies on incorporated GOIC show increased stability against the proteases in the collagen matrix. In this study, GOIC film and collagen film (CF) are used as dressing material on the wound of streptozotocin-induced diabetic rats. A significant increase in ROS (p < 0.05) was observed in the fibroblast of GOIC group during the inflammation period compared to the CF and control groups. This elevated level up regulated the antioxidant status in the granulation tissue and improved cellular proliferation in the GOIC group. Interestingly, our biochemical parameters nitric oxide, hydroxyproline, uronic acid, protein, and DNA content in the healing wound showed that there is an increase in proliferation of cells in GOIC when compared to the control and CF groups. In addition, evidence from wound contraction and histology reveals faster healing in the GOIC group. Our observations document that GOIC matrices could be effectively used for diabetic wound healing therapy.

27 May 2008 in Life Sciences
Verified
Journal Article
Closed access
MGMasilamoni J. Gunasingh
Masilamoni J. Gunasingh
JPJesudason E. Philip
Jesudason E. Philip
BABen S. Ashok
Ben S. Ashok
RKR. Kirubagaran
R. Kirubagaran
CWCharles Emmanuel Jebaraj Walter
Charles Emmanuel Jebaraj Walter
RJR. Jayakumar
R. Jayakumar

1 August 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
DGDicky John Davis G
Dicky John Davis G
Hannah Rachel VasanthiHannah Rachel Vasanthi
Hannah Rachel Vasanthi

12 April 2020 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
CWCharles Emmanuel Jebaraj Walter
Charles Emmanuel Jebaraj Walter
SDSankari Durairajan
Sankari Durairajan
KPKalaiselvi Periyandavan
Kalaiselvi Periyandavan
George Priya Doss C.George Priya Doss C.
George Priya Doss C.
DGDicky John Davis G
Dicky John Davis G
HZHatem Zayed
Hatem Zayed
Introduction: Bladder cancer is the second most common genitourinary tract cancer and is often recurrent and/or chemoresistant after tumor resection. Cigarette smoking, exposure to aromatic amines, and chronic infection/inflammation are bladder cancer risk factors. NF-κB is a transcription factor that plays a critical role in normal physiology and bladder cancer. Bladder cancer patients have constitutively active NF-κB triggered by pro-inflammatory cytokines, chemokines, and hypoxia, augmenting carcinogenesis and progression. Areas covered: NF-κB orchestrates protein interactions (PTEN, survivin, VEGF), regulation (CYLD, USP13) and gene expression (Trp 53) resulting in bladder cancer progression, recurrence and resistance to therapy. This review focuses on NF-κB in bladder inflammation, cancer and resistance to therapy. Expert opinion: NF-κB and bladder cancer necessitate further research to develop better diagnostic and treatment regimens that address progression, recurrence and resistance to therapy. NF-κB is a master regulator that can act with or on minimally one cancer hallmark gene or protein, leading to bladder cancer progression (Tp53, PTEN, VEGF, HMGB1, CYLD, USP13), recurrence (PCNA, BcL-2, JUN) and resistance to therapy (P-gp, twist, SETD6). Thus, an understanding of bladder cancer in relation to NF-κB will offer improved strategies and efficacious targeted therapies resulting in minimal progression, recurrence and resistance to therapy.

1 February 2022 in Marine Genomics
Verified
Journal Article
Closed access
MMMidhuna Immaculate Joseph Maran
Midhuna Immaculate Joseph Maran
DGDicky John Davis G
Dicky John Davis G